{"id":"W2112234259","doi":"10.1345/aph.1k013","title":"Evolution of Peroxisome Proliferator-Activated Receptor Agonists","year":2007,"lang":"en","type":"review","venue":"Annals of Pharmacotherapy","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"ca_institutions":"North York General Hospital","funders":"","keywords":"PPAR agonist; Pioglitazone; Peroxisome proliferator-activated receptor; Medicine; Internal medicine; Partial agonist; Agonist; Endocrinology; Dyslipidemia; Pharmacology; Type 2 diabetes; Diabetes mellitus; Peroxisome proliferator-activated receptor gamma; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003209115,0.0005563375,0.00116816,0.004081727,0.0002022658,0.001551134,0.0006913715,0.00115758,0.006081008],"category_scores_gemma":[0.005289871,0.0002804154,0.001032253,0.004122972,0.0003675501,0.002052905,0.0005857253,0.001575835,0.001824924],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001035221,"about_ca_system_score_gemma":0.001272005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007943613,"about_ca_topic_score_gemma":0.001783582,"domain_scores_codex":[0.9979831,0.0007217467,0.0004540445,0.0002337763,0.0005329684,0.00007438947],"domain_scores_gemma":[0.9970286,0.00157434,0.0006092833,0.00006415995,0.0006486312,0.00007500873],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001143512,0.0001587329,0.001477146,0.04956491,0.0005212449,0.0005808897,0.0002171381,0.0006043644,0.003584519,0.006623853,0.02236666,0.913157],"study_design_scores_gemma":[0.0002706356,0.0007380327,0.004607519,0.03504439,0.0007094381,0.002436341,0.0001823221,0.0002034518,0.001665638,0.002308948,0.951789,0.00004439842],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001403239,0.9882199,0.0005419159,0.003615283,0.0007108995,0.00005047833,0.0003171109,0.00001680123,0.005124468],"genre_scores_gemma":[0.007523627,0.9812615,0.002206826,0.005200936,0.00109098,0.0001279029,0.0004809871,0.00001289512,0.002094374],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006081008,"threshold_uncertainty_score":0.02034301,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0933085215072082,"score_gpt":0.4178744862208326,"score_spread":0.3245659647136244,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}